AC Immune S.A.ACIUNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank18
5Y CAGR+17.2%
Year-over-Year Change

Enterprise value to sales ratio

5Y CAGR
+17.2%/yr
Long-term compound
Percentile
P18
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20247.82-58.8%
202318.99-42.0%
202232.72-
20210.00-100.0%
202011.05+212.1%
20193.54-93.9%
201858.24+90.9%
201730.51+39.0%
201621.95+8.5%
201520.22-